The broken protein wasn't just absent—it was actively poisoning the cell
In the quiet aftermath of a young child's death from an unexplained lung disease, researchers at Washington University have named what could not be named in time: a spontaneous mutation in the RAB5B gene that did not merely silence a protein, but turned it against the very cells it was meant to serve. The discovery, made possible through the NIH's Undiagnosed Diseases Network, arrives too late for one family yet opens a door for the many others living in the shadow of a diagnosis without a name. Science, at its most humbling, sometimes solves its mysteries only after the cost has already been paid.
- A toddler's lungs slowly scarred and failed over years while doctors searched in vain for a genetic cause among the known culprits — and found none.
- The RAB5B mutation proved especially dangerous not because it disabled a protein, but because it actively poisoned surrounding cellular machinery, overwhelming the one healthy gene copy the child carried.
- Researchers from Washington University, Baylor College of Medicine, and the NIH's Undiagnosed Diseases Network pooled expertise across genetics, bioinformatics, and pediatric lung biology to sift thousands of variants down to one.
- Testing in roundworms confirmed the mutation's toxic dominance — a single abnormal copy required three normal copies to counteract, a finding that clarified both the mechanism and the child's fate.
- The mutation arose spontaneously in the embryo, meaning the parents bear no inherited risk — a painful but vital truth that reshapes their future family planning.
- RAB5B sequencing may now offer a diagnostic answer to the many children worldwide carrying interstitial lung disease without explanation, guiding treatment decisions and preparing families for what lies ahead.
A child born apparently healthy began to deteriorate in their second year of life, lungs slowly stiffening and scarring in a pattern doctors recognized but could not explain. Every known genetic cause of interstitial lung disease was ruled out. The child died before an answer arrived.
The case had been referred to Washington University through the NIH's Undiagnosed Diseases Network, a collaborative program designed for exactly these moments — when a patient's condition defeats the resources of any single institution. Researchers sequenced the child's DNA and the parents' genetic code, then worked with bioinformatics specialists at Baylor College of Medicine to sort through thousands of variants in search of the one that mattered.
The lung tissue pointed toward a surfactant problem — the lipid-protein mixture that keeps air sacs open was not functioning — but none of the usual surfactant genes were at fault. The culprit turned out to be RAB5B, a gene responsible for packaging surfactant into cellular compartments and routing it correctly. The mutation had not simply broken the protein; it had corrupted it into something actively harmful. As geneticist Tim Schedl described it, the damaged protein was not merely absent — it was poisoning other cellular processes.
Roundworm models confirmed the finding's severity: a single abnormal copy of the gene overwhelmed one normal copy entirely, requiring three healthy copies to restore function. The child had inherited only one of each. Crucially, neither parent carried the mutation — it had arisen spontaneously during embryonic development, unpredictable and unpreventable, and would pose virtually no risk to future children.
The discovery reframes what is possible for families still waiting for answers. Pediatrician Jennifer Wambach noted that many children carry a clinical diagnosis of interstitial lung disease with no genetic explanation, and RAB5B sequencing may now fill that gap. Knowing the cause allows physicians to anticipate disease progression, weigh transplant options, and help families plan. One child's case, solved after the fact, may now spare others the long uncertainty of an unnamed disease.
A 2-year-old child born without apparent illness developed a progressive lung disease that doctors could not explain. The child's lungs gradually scarred and stiffened, making each breath harder than the last, until the disease took their life. Only after the child had died did researchers at Washington University School of Medicine solve the mystery: a single mutated gene, RAB5B, had been sabotaging the lungs from within.
The case arrived at Washington University as part of the National Institutes of Health's Undiagnosed Diseases Network, a collaborative effort to identify rare and previously unknown diseases in patients whose conditions baffle their doctors. Interstitial lung disease—a broad category in which lung tissue gradually deteriorates and scars—has been linked to several genetic abnormalities, but some patients carry the disease despite having none of the known culprits. This child was one of them. Researchers sequenced the child's DNA alongside the parents' genetic code, then worked with bioinformatics specialists at Baylor College of Medicine to sift through thousands of genetic variants, most of them harmless, searching for the actual cause.
The lung tissue showed a clear problem: the surfactant—a complex mixture of proteins and lipids that keeps the air sacs open and allows oxygen and carbon dioxide to move in and out—was not working properly. Normally, when doctors see this pattern, they look for mutations in the genes that code for surfactant proteins themselves. This child had none. Instead, the researchers found a variant in RAB5B, a gene that produces a protein responsible for packaging surfactant into tiny compartments called vesicles and shuttling them to the right places in the cell. The mutation did not simply disable the protein. It corrupted it in a way that made it actively poisonous to the cell's machinery.
Tim Schedl, a co-senior author and professor of genetics, explained the distinction: "When mutations happen that break a protein, usually the protein just doesn't work anymore—its function is missing. But this is a case where the broken protein is not only not working, it's actively poisoning other processes." The researchers confirmed this by studying the mutation in roundworms, a standard model organism for genetic research. Worms carrying one abnormal copy of the gene required three normal copies to restore function, proving that the mutated version was not merely absent but actively harmful. The child had inherited only one abnormal copy—and one normal copy was not enough to compensate.
Genetic testing revealed that neither parent carried the mutation. The variant had arisen spontaneously during the child's embryonic development, a random event that could not have been predicted or prevented. This knowledge, while it could not save the child, offered the parents crucial information: future children would have virtually no risk of inheriting the same disease.
The discovery opens a new diagnostic pathway. Jennifer Wambach, an associate professor of pediatrics, noted that many children carry a clinical diagnosis of interstitial lung disease without any genetic explanation. "For these patients, sequencing RAB5B may reveal changes in their DNA code that could account for their disease," she said. Knowing the underlying cause allows doctors to predict how the disease will progress, whether a child might respond to treatment, whether a lung transplant may eventually be necessary, or whether the family should prepare for end-of-life care. Stephen Pak, another co-senior author, emphasized the broader significance: "Because these types of genetic diseases are so rare, there's very little information out there for patients or families. But collectively, there are millions of people who live with rare genetic diseases." The Undiagnosed Diseases Network exists precisely to bring together specialists—bioinformaticians, lung biologists, pediatricians, geneticists—to solve these medical mysteries that individual doctors and hospitals cannot crack alone. One child's case, solved too late to help them, may now illuminate the path for others.
Citas Notables
The broken protein is not only not working, it's actively poisoning other processes. This results in the loss of the surfactants in the lungs.— Tim Schedl, co-senior author and professor of genetics
Knowing the underlying genetic cause and identifying other patients with the same genetic problem can help us better predict the course of the disease and prepare patients and their families for what is to come.— Jennifer Wambach, associate professor of pediatrics
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that the protein was actively harmful rather than simply broken?
Because it changes how the disease works. If the protein just stopped functioning, one normal copy might be enough to do the job. But this mutated version was poisoning the cell's machinery—it was like having a saboteur in the factory, not just an absent worker. That's why the child needed three normal copies to compensate for one bad one.
How did they narrow down the cause from thousands of genetic variants to this one gene?
They started with a clue from the lung tissue itself. The surfactant wasn't working right. Most doctors would look for mutations in the surfactant genes directly. But this child didn't have those. So they had to think sideways—what if the problem wasn't in the surfactant genes themselves, but in the machinery that processes and moves the surfactant? That's where RAB5B came in.
The child died before they found the answer. Does that make the discovery feel incomplete?
It's bittersweet. The diagnosis couldn't save this child, but it gave the parents something they didn't have before: certainty. They know it wasn't inherited, that their future children are safe. And now other families with unexplained lung disease have a new place to look.
What happens next for other children with this disease?
Doctors can now sequence RAB5B in patients with interstitial lung disease of unknown cause. If they find the same mutation, they know what they're dealing with—how fast it will progress, what treatments might help, when to prepare for transplant or end-of-life care. That knowledge changes everything for a family.